Transarterial Chemoembolisation Using Doxorubicin Beads for Unresectable Hepatocellular Carcinoma

Publisher： Karger

E-ISSN： 2296-5262|33|1-2|5-6

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.33, Iss.1-2, 2010-01, pp. : 5-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A Randomized Phase II Study of Drug-Eluting Beads versus Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma

By  

Oncology Research and Treatment, Vol. 34, Iss. 7, 2011-06 ,pp. : 368-376

Karger

Access to resources Recommend Favorite

Preservation of quality of life with doxorubicin drug‐eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma: Longitudinal prospective study

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 7, 2015-07 ,pp. : 1167-1174

John Wiley & Sons Inc

Access to resources Recommend Favorite

Acute Eosinophilic and Neutrophilic Pneumonia following Transarterial Chemoembolization with Drug-Eluting Beads Loaded with Doxorubicin for Hepatocellular Carcinoma: A Case Report

By  

Respiration, Vol. 88, Iss. 5, 2014-10 ,pp. : 426-429

Karger

Access to resources Recommend Favorite

HCC O‐23: Outcome of patients with hepatocellular carcinoma treated with transarterial chemoembolisation

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 13-14

John Wiley & Sons Inc

Access to resources Recommend Favorite

Early Prediction of the Outcome Using Tumor Markers and mRECIST in Unresectable Hepatocellular Carcinoma Patients Who Underwent Transarterial Chemoembolization

By  

Oncology, Vol. 91, Iss. 6, 2016-10 ,pp. : 317-330

Karger

Access to resources Recommend Favorite